Canada markets open in 6 hours 59 minutes

Lexaria Bioscience Corp. (LEXX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6200-0.1400 (-5.07%)
At close: 04:00PM EDT
2.7500 +0.13 (+4.96%)
After hours: 07:33PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 37.53M
Enterprise Value 32.88M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)55.83
Price/Book (mrq)5.75
Enterprise Value/Revenue 81.25
Enterprise Value/EBITDA -7.22

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 3263.89%
S&P500 52-Week Change 323.89%
52 Week High 36.8500
52 Week Low 30.7050
50-Day Moving Average 33.0751
200-Day Moving Average 32.2055

Share Statistics

Avg Vol (3 month) 3230.08k
Avg Vol (10 day) 3142.23k
Shares Outstanding 514.32M
Implied Shares Outstanding 615.09M
Float 810.86M
% Held by Insiders 111.49%
% Held by Institutions 16.20%
Shares Short (Jun 14, 2024) 4152.96k
Short Ratio (Jun 14, 2024) 40.54
Short % of Float (Jun 14, 2024) 41.12%
Short % of Shares Outstanding (Jun 14, 2024) 41.07%
Shares Short (prior month May 15, 2024) 4157.45k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 12, 2021
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug 31, 2023
Most Recent Quarter (mrq)Feb 29, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-460.69%

Management Effectiveness

Return on Assets (ttm)-59.36%
Return on Equity (ttm)-101.49%

Income Statement

Revenue (ttm)404.73k
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)624.10%
Gross Profit (ttm)N/A
EBITDA -5.18M
Net Income Avi to Common (ttm)-5.44M
Diluted EPS (ttm)-0.6700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.79M
Total Cash Per Share (mrq)0.37
Total Debt (mrq)148.88k
Total Debt/Equity (mrq)2.42%
Current Ratio (mrq)66.29
Book Value Per Share (mrq)0.53

Cash Flow Statement

Operating Cash Flow (ttm)-5.21M
Levered Free Cash Flow (ttm)-3.45M